2010 · 11 citations · 10 references
PharmacyOncologyPharmacologyChemotherapyClinical PharmacologyPharmacovigilanceAdverse Drug Event DetectionAdverse Drug Event ReportingAdverse Drug Reaction MonitoringAdverse Drug Reaction ReportingAdverse Drug ReactionsDrug Safety MonitoringAdverse Drug Reaction AnalysisAdverse Drug Reaction SurveillanceAnticancer ChemotherapyDrug Safety SurveillanceOncology PharmacovigilanceSerious Adverse Drug ReactionsSuspected Adverse Drug Reaction ReportingSuspected Adverse Reaction Assessment
Adverse drug reactions (ADRs) are a global problem and substantially add to the cost of healthcare. They are likely to be encountered more frequently in hospital in-patient settings where patients receive multiple drugs. Anticancer drugs are prone to cause ADRs and there is dearth of pharmacovigilance data on such drugs in the Indian context. Therefore the present study was planned to monitor suspected ADRs in the oncology unit of a tertiary care teaching hospital, in a focused manner, and to understand the strengths and limitations of cross-sectional observational pharmacovigilance activity for anticancer drugs. A total of 509 drugs were incriminated, with 507 being administered by intravenous route. The most frequently incriminated drugs (those accounting for more than 5% of the total count of 509) were cisplatin, 5-fluorouracil, cyclophosphamide, paclitaxel, carboplatin and doxorubicin, in that order. Of the 296 events, 9.83% were severe and 5.76% were serious. However, there were no fatal or life-threatening events. Causality assessment showed a certain association for 1.84% of the events, probable or likely association for 85.28% and possible association for 12.88%. There was no event less convincing than possible. The frequency of ADRs, easy identification of acute treatment-emergent events and the cooperation offered by patients in the clinical surroundings were the strengths of this method of monitoring for suspected ADRs. On the other hand, the limitations were the inability to identify ADRs that require serial clinical or laboratory monitoring and the lack of scope for picking up chronic or delayed ADRs.
10
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Munir Pirmohamed, Sally James, Shaun Meakin et al. · BMJ · 2004 · 3.2K citations · Full text
Adverse drug reactions. A critical review.
Louis Lasagna · PubMed · 1975 · 174 citations